Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Neural Regulation01:37

Neural Regulation

39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Human Genetics01:28

Human Genetics

570
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
570
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosomal LINC00323 accelerates angiogenesis through activating the MAPK and JAK-STAT pathways by stabilizing CDC5L in NSCLC.

Cellular oncology (Dordrecht, Netherlands)·2026
Same author

Restaging pN Classification in Early Gastric Cancer with Inadequate Lymph Node Retrieval: Multi-Institutional Development and Prognostic Validation of a Revised Staging System.

International journal of general medicine·2026
Same author

A lower LDL-c/ApoB ratio is associated with an increased prevalence of gallstones in the regional Chinese adult population, according to a retrospective, propensity-matched analysis.

Frontiers in physiology·2026
Same author

Correction: Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer.

Frontiers in immunology·2025
Same author

Pan-cancer landscape of ITGAV and its potential role in gastric cancer.

Scientific reports·2025
Same author

Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer.

Frontiers in immunology·2025

Related Experiment Video

Updated: Jul 4, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K

Systemic inflammation and risk of Parkinson's disease: A prospective cohort study and genetic analysis.

Chunyu Li1, Bin Ke1, Jianhai Chen2

  • 1Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Brain, Behavior, and Immunity
|February 9, 2024
PubMed
Summary

Systemic inflammation, measured by C-reactive protein (CRP), is linked to a reduced risk of Parkinson's disease (PD). This finding offers new insights into inflammation's role in PD development and potential therapeutic strategies.

Keywords:
C-reactive proteinGenetic correlationParkinson’s diseasePolygenic risk scoreUK Biobank

More Related Videos

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.0K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.3K

Related Experiment Videos

Last Updated: Jul 4, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.0K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.3K

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Parkinson's disease (PD) is complexly linked to systemic inflammation, with inconsistent findings regarding C-reactive protein (CRP) and interleukin-6 (IL-6).
  • The precise relationship and direction of effect between inflammation markers and PD risk remain controversial in existing research.

Purpose of the Study:

  • To investigate the association between baseline levels of CRP and IL-6 and the subsequent risk of developing PD.
  • To explore the genetic underpinnings of the relationship between CRP, IL-6, and PD risk.

Main Methods:

  • Utilized UK Biobank data to analyze CRP and IL-6 associations with incident PD risk using Cox regression.
  • Conducted genetic analyses including genetic correlation, polygenic risk scores (PRS), and pleiotropic enrichment using GWAS summary statistics.

Main Results:

  • Elevated baseline CRP levels were significantly associated with a lower risk of PD (HR=0.85, P=4.23E-07), consistent across subgroups.
  • Genetic analyses revealed a negative genetic correlation between CRP and PD risk (correlation=-0.14, P=6.31E-05), with higher CRP PRS linked to lower PD risk.
  • No significant association was found between IL-6 and PD risk.

Conclusions:

  • Systemic inflammation, indicated by CRP levels, is associated with a decreased risk of future PD.
  • These findings enhance understanding of inflammation's role in PD pathogenesis.
  • The results have implications for designing future clinical trials and therapeutic interventions targeting inflammation in PD.